Multi-Agent System for Clinical Trials: Blueprint from a 10-Pharma Consortium That Cut Screening by 45%

Introduction: The Multi-Agent Pilot at a Glance As of May 24, 2026, a consortium of ten top pharmaceutical companies has published the first public benchmark of a multi-agent system for clinical trials deployed on AWS Bedrock. The pilot achieved a 45% reduction in patient screening time and a 30% decrease in protocol deviation reporting lag—metrics that operations leaders in pharmaceutical R&D have been waiting for. The system used three specialized agents: a patient data extraction agent built on Alibaba Cloud’s Qwen 3.8 Max, an eligibility matching agent powered by Meta’s Llama 5, and a coordination agent for trial site allocation. All agents were orchestrated via AWS Bedrock AgentCore, now generally available. This article unpacks the architecture, data pipeline, and concrete ROI so you can evaluate similar deployments in your own R&D units. System Architecture: Agent Roles and Orches

tration on AWS Bedrock The multi-agent architecture is a vendor-neutral design pattern that any organization can replicate. The consortium chose AWS Bedrock for its managed multi-agent orchestration layer, but the principles apply to any cloud platform. Agent 1: Patient Data Extraction Agent - Model : Qwen 3.8 Max (Alibaba Cloud) – fine-tuned for healthcare text comprehension. - Role : Extracts structured patient data from electronic medical records (EMRs), lab results, and physician notes. - Output : A standardized JSON payload with demographics, diagnosis codes, medication history, and key biomarkers. Agent 2: Eligibility Matching Agent - Model : Llama 5 (Meta) – optimized for rule-based and semantic reasoning. - Role : Compares extracted patient data against trial protocols to determine eligibility. Handles complex inclusion/exclusion criteria, including temporal logic (e.g., “no prio

r treatment in the last 6 months”). - Output : A ranked list of eligible patients with confidence scores and reasoning traces. Agent 3: Trial Site Allocation Agent - Model : A lightweight coordination agent built on Anthropic’s Claude 4 (Sonnet) – used for decision logic and constraint satisfaction. - Role : Assigns patients to trial sites based on site capacity, geographic proximity, and regulatory jurisdiction. It also forecasts site enrollment rates and flags potential bottlenecks. - Output : An allocation plan with expected timelines and risk flags. Orchestration with AWS Bedrock AgentCore Agents communicate via a shared message queue. The orchestration layer handles task delegation, error recovery, and audit logging. Each agent’s output is validated against a schema before being passed to the next agent, ensuring data integrity throughout the pipeline. Data Pipeline: From EMR to Age

nt-Ready Inputs A critical success factor was the data pipeline design. The consortium faced the same challenge as most pharma organizations: heterogeneous, unstructured EMR data across multiple legacy systems. Step 1: Data Ingestion and Normalization - Raw EMR exports (HL7 FHIR, CSV, PDF) are ingested into an Amazon S3 data lake. - AWS Glue jobs normalize fields into a common schema (patient demographics, diagnoses, medications, lab results). Step 2: Patient Data Extraction Agent - The Qwen 3.8 Max agent receives normalized records and extracts structured attributes. It uses a retrieval-augmented generation (RAG) pipeline with a vector store of medical ontologies (SNOMED CT, ICD-10) to resolve abbreviations and synonyms. - Output is stored in a staging database with a versioned change log for audit trails. Step 3: Eligibility Matching Agent - The Llama 5 agent reads trial protocols (str

uctured as a rule set in a knowledge graph) and evaluates each patient record. - For each criterion, it generates a boolean pass/fail and a natural-language explanation. The agent can also flag ambiguous cases for human review. - A confidence threshold of 0.85 is used; below that, the record is routed to a clinical reviewer. Step 4: Site Allocation and Coordination - The coordination agent receives the eligible patient list and site constraints (capacity, IRB approval status, staffing). It solves a constrained optimization problem and outputs an allocation table. - All outputs are logged to Amazon Simple Storage Service (S3) for reproducibility and regulatory audits. ROI Benchmarks: Screening Time and Protocol Deviation Reduction The consortium published the following metrics from a 6-month pilot across 12 therapeutic areas: Metric Baseline (Manual) Multi-Agent System Improvement -------

- ------------------- ------------------- ------------- Patient screening time per trial 240 hours average 132 hours average 45% reduction Protocol deviation reporting lag 14 days average 10 days average 30% decrease Eligibility matching accuracy 78% (human review) 91% (agent + human validation) +13